InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-39.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Smith Robin L. Director active across 2 companies, notably Sorrento Therapeutics, Inc.. In total, 4 disclosures have been published. Activity tracked since 3 September 2021. The latest transaction was disclosed on 14 June 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
199,921 shares0Class A Common StockSEC:0000899243-23-015880:0
36,145 shares0Class A Common StockSEC:0000899243-22-026186:0
75,000 shares@ US$3.950.060% mcap50.0% of flowCommon StockSEC:0001209191-21-054841:0
75,000 shares@ US$3.9550.0% of flowCommon StockSEC:0001209191-21-054841
4 of 4 declarations
About Smith Robin L
Smith Robin L is a declarant linked to Celularity Inc and Sorrento Therapeutics, Inc., where the listed role is Director. The total number of filings is 4, and across the recent filings available, the modal transaction nature is Attribution, with amounts of EUR 249442.5085044571 on 2021-09-03 for Sorrento Therapeutics, Inc. and EUR 0 for Celularity Inc between 2022-07-15 and 2023-06-16.
